Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:disease
|
| gptkbp:affects |
neuromuscular junction
|
| gptkbp:associatedWith |
gptkb:Small_Cell_Lung_Cancer
|
| gptkbp:cause |
autoimmune response
|
| gptkbp:diagnosedBy |
electromyography
antibody testing |
| gptkbp:differentialDiagnosis |
gptkb:myasthenia_gravis
|
| gptkbp:firstDescribed |
1956
|
| gptkbp:fullName |
gptkb:Lambert-Eaton_myasthenic_syndrome
|
| gptkbp:ICD-10_code |
G73.1
|
| gptkbp:namedAfter |
gptkb:Lee_Eaton
gptkb:Edward_Lambert |
| gptkbp:prevalence |
rare
|
| gptkbp:symptom |
muscle weakness
autonomic dysfunction |
| gptkbp:treatment |
gptkb:3,4-diaminopyridine
gptkb:pyridostigmine immunosuppressive therapy |
| gptkbp:bfsParent |
gptkb:Lunar_Environment_Monitoring_Station
gptkb:Lambert–Eaton_myasthenic_syndrome |
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
LEMS
|